Jan 20 (Reuters) - McKesson Corp will replace some Moderna Inc COVID-19 vaccines in the United States after they arrived colder than the low end of the required temperature range, the company said in a statement on Wednesday. (Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
122.1 USD | -2.30% | +9.42% | +22.81% |
May. 06 | News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET | DJ |
May. 06 | News Highlights : Top Financial Services News of the Day - Monday at 11 AM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+47.02% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B | |
+18.47% | 11.56B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna : McKesson to replace some Moderna COVID-19 vaccines due to low temperature